Sporaxol (itraconazole) capsules 100 mg. №10.


Manufacturer: Spain



Vulvovaginal candidiasis; seeding lichen; dermatomycosis caused by itraconazole-sensitive pathogens (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), such as foot dermatophytosis, inguinal dermatomycosis, trunk dermatophytosis, hand dermatophytosis; oropharyngeal candidiasis; onychomycosis caused by dermatophytes and / or yeast; histoplasmosis; systemic mycoses (in cases where first-line antifungal therapy cannot be applied, or in case of ineffectiveness of treatment with other antifungal drugs, which may be due to pathology, pathogen insensitivity or toxicity of the drug): aspergillosis and candidiasis; cryptococcosis (including cryptococcal meningitis): treatment of immunocompromised patients with cryptococcosis and all patients with cryptococcosis of the central nervous system; supportive therapy in patients with AIDS to prevent recurrence of existing fungal infection. Itraconazole is also prescribed for the prevention of fungal infection in patients with prolonged neutropenia in cases where standard therapy is insufficient.